DEXCOM INC — Director's Dealing 2015

Mar 13, 2015

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: DEXCOM INC (DXCM)
CIK: 0001093557
Period of Report: 2015-03-11

Reporting Person: ROPER JESS (SVP, CFO)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2015-03-11	Common Stock	D	1629.0	$58.7403	Disposed	119183	Direct
2015-03-11	Common Stock	D	5031.0	$58.7402	Disposed	114152	Direct
2015-03-12	Common Stock	D	2669.0	$58.5767	Disposed	111483	Direct

Footnotes

F1: These shares were sold to cover the Company's tax withholding obligation that accrued in connection with the vesting of restricted stock units previously granted.

F2: Included in this number are 70,000 unvested restricted stock units, 40,000 of which were granted on March 8, 2015 and shall vest through March 8, 2018, 20,000 of which were granted on March 8, 2014 and shall vest through March 8, 2017 and 10,000 of which were granted on March 11, 2013 and shall vest through March 11, 2016.